MedTrace Logo

Gabapentin for the Treatment of Hot Flashes in Menopausal Women

NCT00112138 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2011-05-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness and safety of gabapentin compared to placebo in the treatment of hot flashes in postmenopausal women using a phase III randomized controlled trial.

Conditions

Interventions

DRUG

gabapentin

Sponsors & Collaborators

  • North Toronto Primary Care Research Network

    lead NETWORK

Principal Investigators

  • Debra Butt, MSc MD CCFP · North Toronto Primary Care Research Network

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-03-31
Completion
2006-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00112138 on ClinicalTrials.gov